| scholarly article | Q13442814 |
| P2093 | author name string | Nichole R Blatner | |
| Fotini Gounari | |||
| Khashayarsha Khazaie | |||
| P2860 | cites work | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 |
| In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction | Q33778793 | ||
| Cancer inflammation and regulatory T cells | Q33796582 | ||
| Th17 cells in cancer: help or hindrance? | Q34913808 | ||
| Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer | Q37146190 | ||
| Current developments with peptide-based human tumor vaccines | Q37601263 | ||
| The significant role of mast cells in cancer | Q37834484 | ||
| T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis | Q40909943 | ||
| Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer | Q56932821 | ||
| Treg cells in cancer: a case of multiple personality disorder | Q85654516 | ||
| P433 | issue | 5 | |
| P304 | page(s) | e23852 | |
| P577 | publication date | 2013-04-15 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | The two faces of regulatory T cells in cancer | |
| P478 | volume | 2 |
| Q40365857 | Does sunlight protect us from cancer? |
| Q38985262 | Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells |
| Q36963287 | Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer |
| Q40521894 | Quantitative analysis of infiltrating immune cells and bovine papillomavirus type 1 E2-positive cells in equine sarcoids. |
| Q48308048 | Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies |
| Q48123892 | The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer. |
| Q42552005 | Trial Watch: DNA vaccines for cancer therapy |
| Q42737828 | Trial Watch: Lenalidomide-based immunochemotherapy |
Search more.